CNR1 and metabolic syndrome: These effects are due in part to elevation of peripheral EC levels and subsequent over-activation of CB1, since CB1 knock-out mice, or mice chronically treated with CB1 antagonists, exhibit little or no response to high fat diets in terms of body weight gain and increased adiposity, fatty liver, insulin resistance and dyslipidemia [28].